Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ULTRAGENYX PHARMACEUTICAL INC.

(RARE)
  Report
Real-time Estimate Cboe BZX  -  03:41 2022-12-07 pm EST
39.45 USD   +0.59%
11/29Transcript : Ultragenyx Pharmaceutical Inc. Presents at Piper Sandler 34th Annual Healthcare Conference, Nov-29-2022 10:00 AM
CI
11/22Ultragenyx to Present at Piper Sandler Healthcare Conference
GL
11/22Ultragenyx to Present at Piper Sandler Healthcare Conference
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ULTRAGENYX PHARMACEUTICAL INC.
11/29Transcript : Ultragenyx Pharmaceutical Inc. Presents at Piper Sandler 34th An..
CI
11/22Ultragenyx to Present at Piper Sandler Healthcare Conference
GL
11/22Ultragenyx to Present at Piper Sandler Healthcare Conference
GL
11/21Ultragenyx reports inducement grant under nasdaq listing rule 5635(4)
AQ
11/18Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GL
11/18Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
AQ
11/17Transcript : Ultragenyx Pharmaceutical Inc. Presents at 13th Annual Jefferies..
CI
11/15Transcript : Ultragenyx Pharmaceutical Inc. Presents at Stifel 2022 Healthcar..
CI
11/11Ultragenyx Pharmaceutical Chief Financial Officer Mardi Dier to Depart for Private Biop..
MT
11/10Ultragenyx Announces Departure of Chief Financial Officer
GL
11/10Ultragenyx Pharmaceutical Inc. Announces Departure of Mardi Dier, Executive Vice Presid..
CI
11/10Ultragenyx Pharmaceutical Inc. Announces Departure of Mardi Dier, Chief Financial Offic..
CI
11/09Ultragenyx to Present at Upcoming Healthcare Conferences
GL
11/09Ultragenyx to Present at Upcoming Healthcare Conferences
AQ
11/03Credit Suisse Adjusts Ultragenyx Pharmaceutical's Price Target to $96 From $105, Keeps ..
MT
More most relevant news
All news about ULTRAGENYX PHARMACEUTICAL INC.
11/29Transcript : Ultragenyx Pharmaceutical Inc. Presents at Piper Sandler 34th An..
CI
11/22Ultragenyx to Present at Piper Sandler Healthcare Conference
GL
11/22Ultragenyx to Present at Piper Sandler Healthcare Conference
GL
11/21Ultragenyx reports inducement grant under nasdaq listing rule 5635(4)
AQ
11/18Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GL
11/18Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
AQ
11/17Transcript : Ultragenyx Pharmaceutical Inc. Presents at 13th Annual Jefferies..
CI
11/15Transcript : Ultragenyx Pharmaceutical Inc. Presents at Stifel 2022 Healthcar..
CI
11/11Ultragenyx Pharmaceutical Chief Financial Officer Mardi Dier to Depart for Private Biop..
MT
11/10Ultragenyx Pharmaceutical Inc. : Change in Directors or Principal Officers (form 8-K)
AQ
More news
News in other languages on ULTRAGENYX PHARMACEUTICAL INC.
11/11Mardi Dier, directeur financier d'Ultragenyx Pharmaceutical, part pour une société biop..
11/10Ultragenyx Pharmaceutical Inc. annonce le départ de Mardi Dier, vice-président exécutif
11/02Ultragenyx Pharmaceutical Inc. fournit des prévisions de revenus pour 2022
11/02Ultragenyx Pharmaceutical Inc. annonce ses résultats pour le troisième trimestre et les..
10/14Vente d'initiés : Ultragenyx Pharmaceutical
07/28Ultragenyx Pharmaceutical affiche une perte plus importante au 2e trimestre, mais des r..
07/28Earnings Flash (RARE) ULTRAGENYX PHARMACEUTICAL affiche un chiffre d'affaires de 89,3 m..
07/28Ultragenyx Pharmaceutical Inc. Fournit des prévisions de revenus pour l'ensemble de l'a..
07/28Ultragenyx Pharmaceutical Inc. annonce ses résultats pour le deuxième trimestre et les ..
07/19Les actions d'Ultragenyx Pharmaceutical plongent mardi après-midi après les données d'u..
More news
Analyst Recommendations on ULTRAGENYX PHARMACEUTICAL INC.
11/03Credit Suisse Adjusts Ultragenyx Pharmaceutical's Price Target to $96 From $105, Keeps ..
MT
11/03Baird Upgrades Ultragenyx Pharmaceutical to Outperform From Neutral, Adjusts Price Targ..
MT
11/03Wedbush Lowers Ultragenyx Pharmaceutical's PT to $49 From $51, Says Waiting for Additio..
MT
10/13Wedbush Cuts Price Target on Ultragenyx Pharmaceutical to $51 From $68, Maintains Neutr..
MT
10/13Guggenheim Upgrades Ultragenyx Pharmaceutical to Buy From Neutral; Price Target is $50
MT
More recommendations
Press releases
11/22Ultragenyx to Present at Piper Sandler Healthcare Conference
GL
11/22Ultragenyx to Present at Piper Sandler Healthcare Conference
GL
11/21Ultragenyx reports inducement grant under nasdaq listing rule 5635(4)
AQ
11/18Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GL
11/18Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
AQ
More press releases
Upcoming event on ULTRAGENYX PHARMACEUTICAL INC.